Veeva Systems Inc.
General ticker "VEEV" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $34.7B (TTM average)
Veeva Systems Inc. follows the US Stock Market performance with the rate: 15.4%.
Estimated limits based on current volatility of 2.2%: low 301.44$, high 314.72$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 7928 (+8.7%) as of 2026
- North America accounted for 59.6% of revenue in the fiscal year ended 2026-01-31
- Top business risk factors: Market competition, Customer concentration, Security breaches, Dependence on life sciences, Solution defects
- Current price 14.8% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-31 to 2028-01-31
- 2026-01-31 to 2027-01-31 estimated range: [189.61$, 270.46$]
- 2027-01-31 to 2028-01-31 estimated range: [196.54$, 278.33$]
Financial Metrics affecting the VEEV estimates:
- Negative: with PPE of 27.0 at the end of fiscal year the price was high
- Positive: 22.58 < Operating profit margin, % of 28.68
- Positive: 2.37 < Operating cash flow per share per price, % of 3.98
- Positive: 69.38 < Shareholder equity ratio, % of 80.35 <= 81.92
- Positive: -4.49 < Investing cash flow per share per price, % of -3.10
- Positive: Inventory ratio change, % of -0.10 <= 0
- Negative: negative Industry operating income (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term VEEV quotes
Long-term VEEV plot with estimates
Financial data
| YTD | 2024-01-31 | 2025-01-31 | 2026-01-31 |
|---|---|---|---|
| Operating Revenue | $2,363.67MM | $2,746.62MM | $3,195.31MM |
| Operating Expenses | $1,934.34MM | $2,055.18MM | $2,278.94MM |
| Operating Income | $429.33MM | $691.43MM | $916.37MM |
| Non-Operating Income | $158.69MM | $227.95MM | $278.14MM |
| R&D Expense | $629.03MM | $693.08MM | $767.39MM |
| Income(Loss) | $588.02MM | $919.38MM | $1,194.51MM |
| Taxes | $62.32MM | $205.24MM | $285.60MM |
| Net Income(Loss)* | $525.71MM | $714.14MM | $908.91MM |
| Stockholders Equity | $4,644.82MM | $5,832.37MM | $7,214.75MM |
| Assets | $5,910.92MM | $7,339.76MM | $8,979.34MM |
| Operating Cash Flow | $911.34MM | $1,090.05MM | $1,415.22MM |
| Capital expenditure | $26.20MM | $20.52MM | $29.13MM |
| Investing Cash Flow | $-1,076.35MM | $-700.14MM | $-1,104.36MM |
| Financing Cash Flow | $-16.19MM | $26.11MM | $-9.33MM |
| Earnings Per Share** | $3.27 | $4.41 | $5.55 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.